[Federal Register Volume 65, Number 142 (Monday, July 24, 2000)]
[Notices]
[Pages 45603-45604]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-18660]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-00-41]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 639-7090.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques for other 
forms of information technology. Send comments to Anne O'Connor, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.
    Proposed Project: Key Informant Interviews to Identify the Barriers 
to the Implementation of the New Targeted Testing and Treatment of 
Latent TB Infection Recommendations--NEW--In April 2000, the Centers 
for Disease Control and Prevention (CDC) and the American Thoracic 
Society (ATS) issued new recommendations for targeted tuberculin 
testing and treatment regimens for persons with latent tuberculosis 
infection (LTBI.) The

[[Page 45604]]

CDC's National Center for HIV, STD, and TB Prevention (NCHSTP), 
Division of Tuberculosis Elimination (DTBE) proposes to collect data to 
identify potential barriers to the acceptance, implementation, and 
adherence to targeted testing and treatment of LTBI guidelines.
    The specific purpose of this research is:
    A. Identify barriers to acceptance, implementation, and adherence 
to the new targeted testing and treatment of LTBI recommendations.
    B. Identify possible education and communication messages, 
materials, and behavior change strategies to overcome those barriers.
    C. Identify acceptable dissemination and media channels.
    Approximately, one hundred key-informant telephone interviews with 
physicians who evaluate tuberculin skin test results and make treatment 
decisions for individuals with LTBI will be conducted. The target group 
will include physicians who work in the private sector and public 
sector in urban and rural areas from throughout the United States.
    The total cost to the Federal government is estimated at $50,000, 
which includes contract staff and respondent incentives. Key informant 
respondents will receive an incentive of approximately $100 to 
participate in the telephone interview. Using an estimated cost of $100 
per hour, approximately 100 physicians will participate as interview 
respondents; it is estimated their burden will be one hour and their 
cost burden will be $100 (per respondent.) The total estimated cost to 
all respondents is $10,000. The total burden hours are estimated to be 
100.

----------------------------------------------------------------------------------------------------------------
                                                                                          Average
                                                               Number of    Number of     burden/       Total
                         Respondents                          respondents   responses/    response   burden  (in
                                                                            respondent   (in hours)     hours)
----------------------------------------------------------------------------------------------------------------
Physicians (interviewed)....................................          100            1            1          100
                                                             ---------------------------------------------------
    Total...................................................  ...........  ...........  ...........          100
----------------------------------------------------------------------------------------------------------------


    Dated: July 18, 2000.
Nancy Cheal,
Acting Associate Director for Policy, Planning, and Evaluation Centers 
for Disease Control and Prevention (CDC).
[FR Doc. 00-18660 Filed 7-21-00; 8:45 am]
BILLING CODE 4163-18-P